Mutares’ Turnaround Is Real, Yet the Share Price Refuses to Join the Party

The gap between operational reality and market perception rarely gets starker than this. Mutares has just delivered its strongest half-year performance in recent memory — revenue of €3.4 billion and adjusted EBITDA swinging from a minus €89 million loss to a positive €67 million, a swing of more than €150 million year-on-year. The full-year guidance stands confirmed. And the share price response? A shrug.

The stock trades at roughly €25.60–25.90, some 26–27 percent below its 52-week high of €35.15 set in mid-January. Year-to-date, the decline sits at 14 percent. For a company that has spent the summer closing its largest-ever transaction and integrating multiple acquisitions, the market’s indifference is telling.

A summer of blockbuster deals

The first half of 2026 was, by any measure, an acquisition frenzy. In early August, Mutares completed the purchase of SABIC’s technical thermoplastics business across the Americas and Europe for an enterprise value of $450 million — the biggest deal in the company’s history. Shortly after, it closed the acquisition of Magna International’s Car Top Systems business, a unit with roots in the former Mercedes-Porsche joint venture with Magna. The Free2move acquisition was also announced, adding to a pipeline that now demands significant management bandwidth and capital simultaneously.

Mutares confirmed on August 18, alongside its H1 presentation, that it remains in full compliance with all bond covenants — a signal that matters, given the sheer scale of the financing required for these deals. The fact that the company can absorb this much acquisition activity without breaching its debt terms suggests the funding structure for the recent purchases is holding up.

The revenue jump is not what it seems

The top-line surge to €3.4 billion is primarily a consolidation effect — newly acquired businesses are now being folded into the group’s accounts. Mutares’ model has always been buy, restructure, sell, and the current wave of transactions shows the acquisition engine is running at full throttle.

But the quality of that growth is where investors’ skepticism takes root. An adjusted EBITDA of €67 million on a revenue base of €3.4 billion translates to a margin that remains thin by any standard. The revenue jump says little about the sustainability of profitability across the portfolio, and the integration risk from multiple large deals within a short window won’t become fully visible for several quarters.

Should investors sell immediately? Or is it worth buying Mutares?

The real test: holding-level net income

The central question for the second half is not whether the operating businesses are improving — they clearly are — but whether the holding company can deliver on its stated target. Mutares has guided to a holding net income range of €165 million to €200 million for fiscal 2026, a figure that hinges almost entirely on exit activity in H2.

Unlike group revenue, which is spread broadly across the portfolio, the holding result depends directly on how many portfolio companies Mutares actually sells in the coming months, and at what valuations. Management has signaled that H2 2026 will be defined by further exits. Whether those materialize on schedule and at the planned prices will determine if the guidance remains credible or becomes a hollow target.

Two scenarios, one share price

The bull case rests on the operational foundation. The EBITDA improvement of more than €150 million within a year demonstrates that acquired and restructured portfolio companies are gaining earnings power. Both the SABIC thermoplastics deal and the Car Top Systems acquisition are fully closed and integrated — not merely announced. If the promised exits land in H2, the holding guidance could be reached or even exceeded, and the stock, trading at a technically oversold level with an RSI around 32, would have room for a rebound.

The bear case is about execution risk. Exit processes at holding companies are time-sensitive and depend on M&A market conditions that can deteriorate within months. If announced sales stall or close at worse terms than planned, Mutares would miss its own range — a scenario the market appears to be partially pricing in already. The stock trades below both its 50-day and 200-day moving averages, indicating an established downtrend that positive headlines have so far failed to break.

What to watch next

The near-term catalyst is clear: progress on the exit front. Mutares has said the second half will be defined by divestments, and the next quarterly reports will show whether those processes are advancing. For now, the market is taking a wait-and-see posture — rewarding neither the operational turnaround nor the acquisition spree until the holding-level numbers back the story up.

The shares sit at a level where positive surprises could trigger a re-rating. But the burden of proof rests with management to show that the acquisition machine can also be an exit machine — and that the €165 million to €200 million holding guidance is a promise, not a projection.